Div: How does liver failure affect pharmacology of drugs
Definition & Types of Liver Failure
- Liver failure = impaired metabolic & synthetic function of liver
- CLD = associated with more predictably impaired metabolism
- ALD (acute liver failure) = associated with severely impaired drug metabolism
- Alcoholic liver disease → may result in ↑metabolism due to enzyme induction
Pharmacokinetics
Absorption
- ↓abs 2° portal HTN & interstitial oedema
- ↓abs fat soluble drugs (Vit K) 2° ↓ bile salts
- ↑OBA (morphine) 2° ↓1st pass metabolism
Distribution
- ↓plasma protein synthesis = ↑free drug
- ↑VD for lipophilic drugs (PPF)
- ↑ECF volume 2° ascites = ↑VD hydrophilic drug (NDMR)
- ↓pH = alters ionisation of acid/base
- ↑free drug → normally matched by ↑drug clearance because unbound drug metabolised, but unbound drug may be affected by ↓metabolic capacity of liver
- ↓plasma protein synthesis = ↑free drug
Metabolism
- ↓BF 2° portal shunts = ↓metabolism of drugs with high HER
- ↓biotransformation phase 1 & 2 reactions = ↓metabolism of drugs with low HER
- ↓plasma cholinesterase synthesis = prolonged actions of sux, mivacurium
Elimination
- ↓biliary drug clearance
- ↓renal drug clearance 2° hepatorenal syndrome
- ↓PPB = ↑renal clearance
Pharmacodynamics
Encephalopathy
- ↑effect of BZD, M, PPF
Coagulopathy
- ↑effect of anticoagulants
- ↓platelet production 2 ° splenomegaly
↑Hepatotoxicity
- ↓Hepatic enzyme = ↑risk paracetamol toxicity + ↑risk of moving to zero order kinetics
Fluid Balance/Electrolytes
- Ascites → ↑aldosterone 2° intravascular depletion → ↑Na/↓K
Drug Monitoring/Dosing
PPB
- ↑VD → alters loading dose
- ↓Clearance → alters maintenance dose
- Drug monitoring → measures bound + unbound [drug] ∴may underestimate [drug]